News

J.P. Morgan analyst Sandeep Deshpande maintained a Buy rating on ASML Holding NV (0QB8 – Research Report) today and set a price target of €1,057.00. The company’s shares closed last Friday ...
Howmet Aerospace (HWM), which supplies parts for planes built by Airbus (EADSY) and Boeing (BA), could halt some shipments if they are impacted ...
In its first quarter 2025 investor letter, LVS Advisory emphasized stocks such as ICON Public Limited Company (NASDAQ:ICLR). Headquartered in Dublin, Ireland, ICON Public Limited Company (NASDAQ ...
Harvard University has been in an escalating battle with the Trump administration heightened last week by a letter it received from the administration that outlined a slew of demands tied to ...
Now, a long forgotten letter may turn that theory on its head, according to Matthew Steggle, a professor of English at Bristol University. The fragments of the letter, addressed to “good Mrs Sha ...
In December, KTNV reported that a Southern Nevada resident had been overbilled by NV Energy for six years, paying more than twice the monthly basic service charge. Carlin Dinola received a letter from ...
Harvard University received a letter from a federal task force Thursday outlining policy demands tied to nearly $9 billion in federal funding, a university spokesperson told CNN. “Harvard ...
A top official from the Donald Trump administration told Harvard University that a controversial letter sent to the institution last week was issued without proper authorisation. The letter ...
In a letter to the President, Mr Gandhi said such a mass termination would leave lakhs of students without enough teachers and destroy the teachers' morale to serve. His letter followed a ...
Fans of Celebrity Big Brother are sure Chris Hughes' letter from home had a hidden message regarding JoJo Siwa. The former Love Island contestant, 32, and reality TV star, 21, have formed a strong ...
Icon Plc and Medpace are both CROs, but Icon focuses on large pharma with an aggressive M&A strategy, unlike Medpace's small biotech focus. Initially impressed by Icon's financials, we purchased ...